Tag: breast cancer

Novartis Kisqali® Phase III NATALEE trial meets primary endpoint at interim analysis for breast cancer

Enhertu granted Breakthrough Therapy Designation in US HER2-low metastatic breast cancer

Sanofi provides update on Phase 2 study evaluating amcenestrant in breast cancer

EC grant Trodelvy marketing authorisation for the treatment of breast cancer

Breast cancer now most common form of cancer: WHO taking action

Enhertu approved in EU for HER2-positive metastatic breast cancer

FDA approves Roche’s Phesgo for HER2-positive breast cancer

Pfizer’s update on phase 3 Pallas Trial of Ibrance® in HR+, HER2- early Breast Cancer

NICE draft guidance recommends new treatment option for people with early breast cancer

FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2-Positive Metastatic Breast Cancer

USFDA accepts Roche’s Biologics License Application for fixed-dose subcutaneous combination of Perjeta and Herceptin for the treatment of HER2-positive breast cancer